From Short‐Term Benefits to Long‐Term Outcomes: The Evolution of Clinical Trials in Pulmonary Arterial Hypertension
Author:
Affiliation:
1. Pulmonary and Critical Care DivisionWashington University School of MedicineSt. LouisMissouriUSA
2. Columbia University College of Physicians and SurgeonsNew YorkNew YorkUSA
Funder
Actelion Pharmaceuticals
Gilead Sciences
United Therapeutics Corporation
Novartis
Bayer
Ikaria
Publisher
Wiley
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1086/674456
Reference68 articles.
1. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT);Galiè N;Eur Heart J,2009
2. The pharmacological treatment of pulmonary arterial hypertension;Frumkin LR;Pharmacol Rev,2012
3. Survival in patients with primary pulmonary hypertension: results from a national prospective registry;D'Alonzo GE;Ann Intern Med,1991
4. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension;Humbert M;Eur Respir J,2010
5. Connective tissue disease–associated pulmonary arterial hypertension in the modern treatment era;Condliffe R;Am J Respir Crit Care Med,2009
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of terminated pulmonary hypertension clinical trials. What are we doing wrong?;Current Problems in Cardiology;2024-10
2. Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository;Pulmonary Circulation;2023-07
3. Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension;Advances in Therapy;2022-07-12
4. Dynamics of 6-Minute Walk Distance as a Predictor of Efficiency Specific Pulmonary Vasodilators;Rational Pharmacotherapy in Cardiology;2022-07-06
5. Dynamics of 6-Minute Walk Distance as a Predictor of Efficiency Specific Pulmonary Vasodilators;RATION PHARMACOTHER;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3